Recent pharmaceutical excessive pricing cases in context

Baker McKenzie global antitrust head Fiona Carlin, assisted by Washington, DC, partner Creighton Macy and Johannesburg partner Nick Altini, examines international trends in excessive pricing enforcement against high generic drug prices - and considers whether the recent spike in activity could be a sign that enforcers are expanding the definition of the infringement.

Unlock unlimited access to all Global Competition Review content